Insider Transactions in Q1 2025 at Cytom X Therapeutics, Inc. (CTMX)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 04
2025
|
Christopher Ogden Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
101,500
+21.98%
|
-
|
|
Feb 04
2025
|
Yu Waye Chu Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
113,500
+34.83%
|
-
|
|
Feb 04
2025
|
Marcia Belvin SVP, Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
87,500
+15.33%
|
-
|
|
Feb 04
2025
|
Sean A. Mc Carthy CEO |
BUY
Grant, award, or other acquisition
|
Direct |
375,000
+16.78%
|
-
|